U.S. Justice Department probing MiMedx’s business practices: Bloomberg

(Reuters) – Regenerative medicine maker MiMedx Group Inc is under federal investigation related to two business practices, Bloomberg reported on Monday, citing people familiar with the matter.

Powered by WPeMatico

Scroll to top